Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Zanubrutinib1件: Zanubrutinib (Zanubrutinib)1件: Zanubrutinib (Zanubrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬7件: 13, 48, 61, 63, 222, 300, 331 💬
2Zanubrutinib 160mg/d1件: Zanubrutinib (Zanubrutinib)1件: Zanubrutinib (Zanubrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
3Zanubrutinib 240mg/d1件: Zanubrutinib (Zanubrutinib)1件: Zanubrutinib (Zanubrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
4Zanubrutinib 80 MG1件: Zanubrutinib (Zanubrutinib)1件: Zanubrutinib (Zanubrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 300 💬
5Zanubrutinib 80mg/d1件: Zanubrutinib (Zanubrutinib)1件: Zanubrutinib (Zanubrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
6Zanubrutinib Oral Capsule1件: Zanubrutinib (Zanubrutinib)1件: Zanubrutinib (Zanubrutinib) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 61 💬